-
1701
-
1702
-
1703
-
1704
-
1705
-
1706
Coexistence of Takayasu’s Arteritis in Patients with Inflammatory Bowel Diseases
Published 2021-01-01Get full text
Article -
1707
Atypical Hemolytic Uremic Syndrome after Traumatic Rectal Injury: A Case Report
Published 2021-12-01Get full text
Article -
1708
Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales
Published 2021-08-01“…Background Evidence from a national clinical audit of early inflammatory arthritis (EIA) shows considerable variability between hospitals in performance, unexplained by controlling for case-mix.Objective To explore the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality EIA care.Methods A qualitative study within 16 purposively sampled rheumatology units across England and Wales. Quality was assessed in relation to 11 quality indicators based on clinical opinion, evidence and variability observed in the data. …”
Get full text
Article -
1709
-
1710
-
1711
Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
Published 2022-01-01Get full text
Article -
1712
-
1713
Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis
Published 2025-04-01“…Oral Janus kinase inhibitors (JAKi) are increasingly used in dermatology, rheumatology, gastroenterology, and hematology. While effective, they can cause adverse effects such as acne, nausea, cytopenia, dyslipidemia, and Herpes zoster. …”
Get full text
Article -
1714
The Pharmacodynamic Impact of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Circulating Levels of Inflammatory Biomarkers in Patients with Psoriatic Arthritis: Substudy Res...
Published 2015-01-01“…Association between biomarker levels and achievement of 20% improvement from baseline in modified American College of Rheumatology (ACR20) response criteria was assessed by logistic regression. …”
Get full text
Article -
1715
Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signatu...
Published 2020-09-01“…Patients ≥18 years old with a physician diagnosis that meets the American College of Rheumatology or Systemic Lupus International Collaborating Clinics SLE classification criteria will be included. …”
Get full text
Article -
1716
-
1717
Central Nervous System Involvement in Henoch-Schonlein Purpura in Children and Adolescents
Published 2017-01-01“…Diagnosis was based on the American College of Rheumatology criteria. Out of 112 children with HSP 1 case (0.9%) had CNS involvement presenting as Posterior Reversible Encephalopathy Syndrome (PRES), which may be a result of CNS vasculitis or arterial hypertension. …”
Get full text
Article -
1718
Varied Presentations Of Patients With Systemic Lupus Erythematosus – What Makes Pakistani Lupus Patients Different
Published 2024-03-01“…Reasons for serious manifestations at initial presentation include deficiency of healthcare professionals trained in the field of Rheumatology and lack of awareness among patients. …”
Get full text
Article -
1719
-
1720
Therapeutic Potential of Stem Cells in Follicle Regeneration
Published 2018-01-01Get full text
Article